Chlordiazepoxide Stats & Data

Chlordiazepoxide has a long elimination time and produces active metabolites (including desmethyldiazepam and oxazepam), so effects and impairment can persist into the next day—avoid redosing and plan for extended sedation. Its CNS depressant effects are synergistic with alcohol, opioids, GHB/GBL, barbiturates, gabapentinoids, first-generation antihistamines, and other sedatives, markedly increasing the risk of respiratory depression and overdose. Because of slow onset (30–60 min) and prolonged peaks (1–4 h), impatience-driven redosing is a common error—wait several hours before judging effect. Driving and safety-sensitive tasks can be impaired for 12–24+ hours; next‑day effects are common at higher doses or with repeated dosing. Tolerance to sedative/anxiolytic effects emerges quickly with regular use; dependence can develop within weeks, so courses should be short and dose minimal. Abrupt cessation after regular use can precipitate severe withdrawal (including seizures); any taper should be gradual and medically supervised. In older adults and in hepatic impairment, accumulation is more likely and sedation/fall risk is higher—use extra caution and lower doses. Do not crush tablets to inject or plug—binders/fillers and poor water solubility create serious vascular risks and unpredictable absorption. Rough oral equivalence is ~25 mg chlordiazepoxide ≈ 10 mg diazepam; interindividual variability means equivalence is only a guide and not a dosing instruction. For people using other depressants (e.g., opioids, alcohol, GHB/GBL, gabapentinoids), avoid concomitant use; if exposure has occurred, reduce doses drastically, do not use alone, and ensure monitoring.